Cargando…

Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone

Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Naeem, Muhammad, Enos, Derek, Shah, Shazia, Patel, Nidhi, Fisher, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359626/
https://www.ncbi.nlm.nih.gov/pubmed/34395132
http://dx.doi.org/10.7759/cureus.16354
_version_ 1783737586680856576
author Naeem, Muhammad
Enos, Derek
Shah, Shazia
Patel, Nidhi
Fisher, Tara
author_facet Naeem, Muhammad
Enos, Derek
Shah, Shazia
Patel, Nidhi
Fisher, Tara
author_sort Naeem, Muhammad
collection PubMed
description Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral doxycycline is administered with a good disease prognosis but we report the case of a 58-year-old male who presented with Lyme disease diagnosed by immunoassay; he was treated with doxycycline but was refractory and saw an improvement in his symptoms with IV ceftriaxone.
format Online
Article
Text
id pubmed-8359626
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-83596262021-08-13 Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone Naeem, Muhammad Enos, Derek Shah, Shazia Patel, Nidhi Fisher, Tara Cureus Internal Medicine Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral doxycycline is administered with a good disease prognosis but we report the case of a 58-year-old male who presented with Lyme disease diagnosed by immunoassay; he was treated with doxycycline but was refractory and saw an improvement in his symptoms with IV ceftriaxone. Cureus 2021-07-13 /pmc/articles/PMC8359626/ /pubmed/34395132 http://dx.doi.org/10.7759/cureus.16354 Text en Copyright © 2021, Naeem et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Naeem, Muhammad
Enos, Derek
Shah, Shazia
Patel, Nidhi
Fisher, Tara
Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
title Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
title_full Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
title_fullStr Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
title_full_unstemmed Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
title_short Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
title_sort management of chronic symptoms of lyme disease with intravenous ceftriaxone
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359626/
https://www.ncbi.nlm.nih.gov/pubmed/34395132
http://dx.doi.org/10.7759/cureus.16354
work_keys_str_mv AT naeemmuhammad managementofchronicsymptomsoflymediseasewithintravenousceftriaxone
AT enosderek managementofchronicsymptomsoflymediseasewithintravenousceftriaxone
AT shahshazia managementofchronicsymptomsoflymediseasewithintravenousceftriaxone
AT patelnidhi managementofchronicsymptomsoflymediseasewithintravenousceftriaxone
AT fishertara managementofchronicsymptomsoflymediseasewithintravenousceftriaxone